NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | -50.0% | 100 | 0.0% | 0.00% | – |
Q2 2023 | $2 | -60.0% | 100 | -66.7% | 0.00% | – |
Q1 2023 | $5 | +66.7% | 300 | 0.0% | 0.00% | – |
Q4 2022 | $3 | -99.9% | 300 | -40.0% | 0.00% | – |
Q3 2022 | $4,000 | +33.3% | 500 | +25.0% | 0.00% | – |
Q2 2022 | $3,000 | -76.9% | 400 | -62.3% | 0.00% | -100.0% |
Q1 2022 | $13,000 | -84.9% | 1,061 | -57.8% | 0.00% | -75.0% |
Q4 2021 | $86,000 | -29.5% | 2,515 | -0.2% | 0.00% | -33.3% |
Q3 2021 | $122,000 | +7.0% | 2,521 | -0.4% | 0.01% | 0.0% |
Q2 2021 | $114,000 | -10.2% | 2,531 | -3.7% | 0.01% | -14.3% |
Q1 2021 | $127,000 | -21.6% | 2,627 | -12.4% | 0.01% | -30.0% |
Q4 2020 | $162,000 | +42.1% | 3,000 | -3.2% | 0.01% | +25.0% |
Q3 2020 | $114,000 | -10.2% | 3,100 | -24.4% | 0.01% | -11.1% |
Q2 2020 | $127,000 | +6.7% | 4,100 | -4.7% | 0.01% | -10.0% |
Q1 2020 | $119,000 | 0.0% | 4,300 | +5.4% | 0.01% | +25.0% |
Q4 2019 | $119,000 | +36.8% | 4,079 | -10.4% | 0.01% | +14.3% |
Q3 2019 | $87,000 | +52.6% | 4,550 | +75.0% | 0.01% | +40.0% |
Q2 2019 | $57,000 | – | 2,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,516,313 | $14,011 | 8.43% |
Greenhouse Funds LLLP | 2,795,231 | $25,827,934 | 2.36% |
First Light Asset Management, LLC | 2,682,171 | $24,783,260 | 2.30% |
PERKINS CAPITAL MANAGEMENT INC | 197,700 | $1,827 | 1.93% |
Altium Capital Management LP | 285,000 | $2,633,400 | 1.34% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,654,543 | $15,287,977 | 0.95% |
EMERALD ADVISERS, LLC | 2,101,567 | $19,418,479 | 0.94% |
Bullseye Asset Management LLC | 105,997 | $980 | 0.53% |
OAK FAMILY ADVISORS, LLC | 101,194 | $935,033 | 0.50% |
FORMULA GROWTH LTD | 180,300 | $1,665,972 | 0.47% |